• 2019

  The World Association of Radiopharmaceutical and Molecular Therapy position statement on the initial radioiodine therapy for differentiated thyroid carcinoma

  Dizdarevic, S. T., M.: McCready, V. R.: Mihailovic, J.: Vinjamuri, S.: Buscombe, J. R.: Lee, S. T.: Frangos, S.: Sathekge, M.: Siraj, Q.: Choudhury, P.: Bom, H.: Franceschi, M.: Ugrinska, A.: Paez, D.: Hussain, R.: Mailman, J.: Luster, M.: Virgolini, I. (2019). The World Association of Radiopharmaceutical and Molecular Therapy position statement on the initial radioiodine therapy for differentiated thyroid carcinoma. World J Nucl Med, 18(2), 123-126. doi:10.4103/wjnm.WJNM_117_18

Bone

• 2018

  SNMMI Procedure Standard for Bone Scintigraphy 4.0 (2018)

  Bartel, T. B., Kuruva, M., Gnanasegaran, G., Beheshti, M., Cohen, E. J., Weissman, A. F., & Yarbrough, T. L. (2018). SNMMI Procedure Standard for Bone Scintigraphy 4.0. J Nucl Med Technol, 46(4), 398-404.

• 2016

  The EANM practice guidelines for Bone Scintigraphy (2016)

  Van den Wyngaert, T., Strobel, K., Kampen, W. U., Kuwert, T., van der Bruggen, W., Mohan, H. K., . . . the Oncology, C. (2016). The EANM practice guidelines for bone scintigraphy. European Journal of Nuclear Medicine and Molecular Imaging, 43(9), 1723-1738. Retrieved from https://doi.org/10.1007/s00259-016-3415-4. doi:10.1007/s00259-016-3415-4

• 2015

  18F-NaF PET/CT: EANM procedure guidelines for bone imaging (2015)

  Beheshti, M., Mottaghy, F. M., Paycha, F., Behrendt, F. F. F., Van den Wyngaert, T., Fogelman, I., . . . Langsteger, W. (2015). (18)F-NaF PET/CT: EANM procedure guidelines for bone imaging. Eur J Nucl Med Mol Imaging, 42(11), 1767-1777. doi:10.1007/s00259-015-3138-y

• 2010

  BSR and BHPR guidelines for the management of giant cell arteritis (2010)

  Dasgupta, B., Borg, F. A., Hassan, N., Alexander, L., Barraclough, K., Bourke, B., . . . Group, A. W. (2010). BSR and BHPR guidelines for the management of giant cell arteritis. Rheumatology, 49(8), 1594-1597. Retrieved from https://doi.org/10.1093/rheumatology/keq039a. doi:10.1093/rheumatology/keq039a

• 2010

  EANM Guidelines for paediatric bone scanning with 99mTc-labelled radiopharmaceuticals and 18F-fluoride?(2010)

  Stauss, J., Hahn, K., Mann, M., & De Palma, D. (2010). Guidelines for paediatric bone scanning with 99mTc-labelled radiopharmaceuticals and 18F-fluoride. European Journal of Nuclear Medicine and Molecular Imaging, 37(8), 1621-1628. Retrieved from https://doi.org/10.1007/s00259-010-1492-3. doi:10.1007/s00259-010-1492-3

• 2010

  SNM Guideline for Sodium F-18-Fluoride PET/CT Bone Scans (2010)

  Segall, G., Delbeke, D., Stabin, M. G., Even-Sapir, E., Fair, J., Sajdak, R., & Smith, G. T. (2010). SNM practice guideline for sodium 18F-fluoride PET/CT bone scans 1.0. J Nucl Med, 51(11), 1813-1820. doi:10.2967/jnumed.110.082263

• 2009

  BSR and BHPR guidelines for the management of polymyalgia rheumatica

  Dasgupta, B., Borg, F. A., Hassan, N., Barraclough, K., Bourke, B., Fulcher, J., . . . Group, A. W. (2009). BSR and BHPR guidelines for the management of polymyalgia rheumatica. Rheumatology, 49(1), 186-190. Retrieved from https://doi.org/10.1093/rheumatology/kep303a. doi:10.1093/rheumatology/kep303a

• 2003

  EANM Bone Scintigraphy: procedure guidelines for tumour imaging?(2003)

  Bombardieri, E., Aktolun, C., Baum, R. P., Bishof-Delaloye, A., Buscombe, J., Chatal, J. F., . . . Reske, S. N. (2003). Bone scintigraphy: procedure guidelines for tumour imaging. Eur J Nucl Med Mol Imaging, 30(12), Bp99-106. doi:10.1007/s00259-003-1347-2

• 2003

  SNM Procedure Guideline for Bone Scintigraphy (2003)

  Donohoe, K. J., Henkin, R. E., Royal, H. D., Brown, M. L., Collier, B. D., O'Mara, R. E., & Carretta, R. F. (1996). Procedure guideline for bone scintigraphy: 1.0. Society of Nuclear Medicine. J Nucl Med, 37(11), 1903-1906

Dosimetry

• 2018

  EANM practical guidance on uncertainty analysis for molecular radiotherapy absorbed dose calculations?(2018)

  ear, J. I., Cox, M. G., Gustafsson, J., Gleisner, K. S., Murray, I., Glatting, G., . . . Flux, G. D. (2018). EANM practical guidance on uncertainty analysis for molecular radiotherapy absorbed dose calculations. European Journal of Nuclear Medicine and Molecular Imaging, 45(13), 2456-2474. Retrieved from https://doi.org/10.1007/s00259-018-4136-7. doi:10.1007/s00259-018-4136-7

• 2013

  EANM Dosimetry Committee Series on Standard Operational Procedures for Pre-Therapeutic Dosimetry II. Dosimetry prior to Radioiodine Therapy of Benign Thyroid Diseases (Supplement) (2013)

  H?nscheid H, Canzi C, Eschner W, et al. EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry II. Dosimetry prior to radioiodine therapy of benign thyroid diseases. Eur J Nucl Med Mol Imaging 2013; 40(7): 1126-34.

• 2013

  EANM Dosimetry Committee Series on Standard Operational Procedures for Pre-Therapeutic Dosimetry II. Dosimetry prior to Radioiodine Therapy of Benign Thyroid Diseases?(2013)

  H?nscheid, H., Canzi, C., Eschner, W., Flux, G., Luster, M., Strigari, L., & Lassmann, M. (2013). EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry II. Dosimetry prior to radioiodine therapy of benign thyroid diseases. Eur J Nucl Med Mol Imaging, 40(7), 1126-1134. doi:10.1007/s00259-013-2387-x

• 2010

  EANM Bone Marrow Dosimetry Guidelines (2010)

  Hindorf, C., Glatting, G., Chiesa, C., Lindén, O., & Flux, G. (2010). EANM Dosimetry Committee guidelines for bone marrow and whole-body dosimetry. Eur J Nucl Med Mol Imaging, 37(6), 1238-1250. doi:10.1007/s00259-010-1422-4

• 2010

  EANM Dosimetry Committee guidance document: good practice of clinical dosimetry reporting?(2010)

  Lassmann, M., Chiesa, C., Flux, G., & Bardiès, M. (2011). EANM Dosimetry Committee guidance document: good practice of clinical dosimetry reporting. Eur J Nucl Med Mol Imaging, 38(1), 192-200. doi:10.1007/s00259-010-1549-3

• 2008

  EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry I: blood and bone marrow dosimetry in differentiated thyroid cancer therapy?(2008)

  Lassmann M, H?nscheid H, Chiesa C, Hindorf C, Flux G, Luster M. EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry I: blood and bone marrow dosimetry in differentiated thyroid cancer therapy. European Journal of Nuclear Medicine and Molecular Imaging 2008; 35(7): 1405.

Drugs development

• 2014

  Guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD)?(2014)

  Todde, S., Windhorst, A. D., Behe, M., Bormans, G., Decristoforo, C., Faivre-Chauvet, A., . . . Elsinga, P. H. (2014). EANM guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD). Eur J Nucl Med Mol Imaging, 41(11), 2175-2185. doi:10.1007/s00259-014-2866-8

• 2008

  Guideline to Regulations for Radiopharmaceuticals in Early Phase Clinical Trials in the EU?(2008)

  Verbruggen, A., Coenen, H. H., Deverre, J. R., Guilloteau, D., Langstrom, B., Salvadori, P. A., & Halldin, C. (2008). Guideline to regulations for radiopharmaceuticals in early phase clinical trials in the EU. Eur J Nucl Med Mol Imaging, 35(11), 2144-2151. doi:10.1007/s00259-008-0853-7

Endocrinology

• 2019

  Additional value of integrated?18F-choline PET/4D contrast-enhanced CT in the localization of hyperfunctioning?parathyroid glands?and correlation with molecular profile.

  Piccardo, A., Trimboli, P., Rutigliani, M., Puntoni, M., Foppiani, L., Bacigalupo, L., . . . Giovanella, L. (2019). Additional value of integrated (18)F-choline PET/4D contrast-enhanced CT in the localization of hyperfunctioning parathyroid glands and correlation with molecular profile. Eur J Nucl Med Mol Imaging, 46(3), 766-775. doi:10.1007/s00259-018-4147-4

• 2019

  Choline PET/CT in parathyroid imaging: a systematic review.

  Broos, W. A. M., van der Zant, F. M., Knol, R. J. J., & Wondergem, M. (2019). Choline PET/CT in parathyroid imaging: a systematic review. Nucl Med Commun, 40(2), 96-105. doi:10.1097/mnm.0000000000000952

• 2019

  Diagnostic performance of choline PET for detection of hyperfunctioning?parathyroid glands?in hyperparathyroidism: a systematic review and meta-analysis.

  Treglia, G., Piccardo, A., Imperiale, A., Strobel, K., Kaufmann, P. A., Prior, J. O., & Giovanella, L. (2019). Diagnostic performance of choline PET for detection of hyperfunctioning parathyroid glands in hyperparathyroidism: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging, 46(3), 751-765. doi:10.1007/s00259-018-4123-z

• 2019

  EANM Practice Guideline/SNMMI Procedure Standard for RAIU and Scintigraphy, V 3.0? (2019)

  Giovanella, L., Avram, A. M., Iakovou, I., Kwak, J., Lawson, S. A., Lulaj, E., . . . Wolin, E. (2019). EANM practice guideline/SNMMI procedure standard for RAIU and thyroid scintigraphy. European Journal of Nuclear Medicine and Molecular Imaging, 46(12), 2514-2525. Retrieved from https://doi.org/10.1007/s00259-019-04472-8. doi:10.1007/s00259-019-04472-8

• 2018

  68Ga-somatostatin receptor analogs and?18F-FDG PET/CT in the localization of metastatic pheochromocytomas and paragangliomas with germline mutations: a meta-analysis.

  Kan, Y., Zhang, S., Wang, W., Liu, J., Yang, J., & Wang, Z. (2018). (68)Ga-somatostatin receptor analogs and (18)F-FDG PET/CT in the localization of metastatic pheochromocytomas and paragangliomas with germline mutations: a meta-analysis. Acta Radiol, 59(12), 1466-1474. doi:10.1177/0284185118764206

• 2018

  Challenging pre-surgical localization of hyperfunctioning?parathyroid glands?in primary hyperparathyroidism: the added value of?18F-Fluorocholine PET/CT.

  Grimaldi, S., Young, J., Kamenicky, P., Hartl, D., Terroir, M., Leboulleux, S., . . . Deandreis, D. (2018). Challenging pre-surgical localization of hyperfunctioning parathyroid glands in primary hyperparathyroidism: the added value of (18)F-Fluorocholine PET/CT. Eur J Nucl Med Mol Imaging, 45(10), 1772-1780. doi:10.1007/s00259-018-4018-z

• 2018

  Clinical significance of patterns of increased [18F]-FDG uptake in the?thyroid gland: a pictorial review.

  Tsubaki, F., Kurata, S., Tani, J., Sumi, A., Fujimoto, K., & Abe, T. (2018). Clinical significance of patterns of increased [(18)F]-FDG uptake in the thyroid gland: a pictorial review. Jpn J Radiol, 36(3), 181-193. doi:10.1007/s11604-017-0715-y

• 2018

  Diagnostic Performance of Technetium-99m Methoxy-Isobutyl-Isonitrile for Differentiation of Malignant Thyroid Nodules: A Systematic Review and Meta-Analysis.

  Kim, S. J., Lee, S. W., Jeong, S. Y., Pak, K., & Kim, K. (2018). Diagnostic Performance of Technetium-99m Methoxy-Isobutyl-Isonitrile for Differentiation of Malignant Thyroid Nodules: A Systematic Review and Meta-Analysis. Thyroid, 28(10), 1339-1348. doi:10.1089/thy.2018.0072

• 2018

  Temporal Uptake Patterns of 18F-Fluorocholine Among Hyperfunctioning?Parathyroid Glands.

  Morland, D., Richard, C., Godard, F., Deguelte, S., & Delemer, B. (2018). Temporal Uptake Patterns of 18F-Fluorocholine Among Hyperfunctioning Parathyroid Glands. Clin Nucl Med, 43(7), 504-505. doi:10.1097/rlu.0000000000002132

• 2017

  Comparison of Core-Needle Biopsy and Fine-Needle Aspiration for Evaluating Thyroid Incidentalomas Detected by?18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: A Propensity Score Analysis.

  Suh, C. H., Choi, Y. J., Lee, J. J., Shim, W. H., Baek, J. H., Chung, H. C., . . . Lee, J. H. (2017). Comparison of Core-Needle Biopsy and Fine-Needle Aspiration for Evaluating Thyroid Incidentalomas Detected by (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: A Propensity Score Analysis. Thyroid, 27(10), 1258-1266. doi:10.1089/thy.2017.0192

• 2017

  Current Concepts in?68Ga-DOTATATE Imaging of Neuroendocrine Neoplasms: Interpretation, Biodistribution, Dosimetry, and Molecular Strategies.

  Bodei, L., Ambrosini, V., Herrmann, K., & Modlin, I. (2017). Current Concepts in (68)Ga-DOTATATE Imaging of Neuroendocrine Neoplasms: Interpretation, Biodistribution, Dosimetry, and Molecular Strategies. J Nucl Med, 58(11), 1718-1726. doi:10.2967/jnumed.116.186361

• 2017

  The diagnostic value of 11C-methionine PET in hyperparathyroidism with negative 99mTc-MIBI SPECT: a meta-analysis.

  Yuan, L., Liu, J., Kan, Y., Yang, J., & Wang, X. (2017). The diagnostic value of 11C-methionine PET in hyperparathyroidism with negative 99mTc-MIBI SPECT: a meta-analysis. Acta Radiol, 58(5), 558-564. doi:10.1177/0284185116661878

• 2017

  The Impact of Somatostatin Receptor-Directed PET/CT on the Management of Patients with Neuroendocrine Tumor: A Systematic Review and Meta-Analysis.

  Barrio, M., Czernin, J., Fanti, S., Ambrosini, V., Binse, I., Du, L., . . . Fendler, W. P. (2017). The Impact of Somatostatin Receptor-Directed PET/CT on the Management of Patients with Neuroendocrine Tumor: A Systematic Review and Meta-Analysis. J Nucl Med, 58(5), 756-761. doi:10.2967/jnumed.116.185587

• 2016

  Detection rate of (99m) Tc-MIBI single photon emission computed tomography (SPECT)/CT in preoperative planning for patients with primary hyperparathyroidism: A meta-analysis.

  Treglia, G., Sadeghi, R., Schalin-J?ntti, C., Caldarella, C., Ceriani, L., Giovanella, L., & Eisele, D. W. (2016). Detection rate of (99m) Tc-MIBI single photon emission computed tomography (SPECT)/CT in preoperative planning for patients with primary hyperparathyroidism: A meta-analysis. Head Neck, 38 Suppl 1, E2159-2172. doi:10.1002/hed.24027

• 2015

  Pitfalls and Limitations of?Radionuclide Imaging?in Endocrinology.

  Agrawal, K., Esmail, A. A., Gnanasegaran, G., Navalkissoor, S., Mittal, B. R., & Fogelman, I. (2015). Pitfalls and Limitations of Radionuclide Imaging in Endocrinology. Semin Nucl Med, 45(5), 440-457. doi:10.1053/j.semnuclmed.2015.02.004

• 2015

  The role of?radionuclide imaging?in the surgical management of primary hyperparathyroidism.

  Hindié, E., Zanotti-Fregonara, P., Tabarin, A., Rubello, D., Morelec, I., Wagner, T., . . . Ta?eb, D. (2015). The role of radionuclide imaging in the surgical management of primary hyperparathyroidism. J Nucl Med, 56(5), 737-744. doi:10.2967/jnumed.115.156018

• 2013

  European thyroid association guidelines for cervical ultrasound scan and ultrasound-guided techniques in the postoperative management of patients with thyroid cancer?(2013)

  Leenhardt, L., Erdogan, M. F., Hegedus, L., Mandel, S. J., Paschke, R., Rago, T., & Russ, G. (2013). 2013 European thyroid association guidelines for cervical ultrasound scan and ultrasound-guided techniques in the postoperative management of patients with thyroid cancer. Eur Thyroid J, 2(3), 147-159. doi:10.1159/000354537

• 2011

  SNM Practice Guideline for Parathyroid Scintigraphy4.0?(2011)

  Greenspan, B. S., Dillehay, G., Intenzo, C., Lavely, W. C., O'Doherty, M., Palestro, C. J., . . . Tulchinsky, M. (2012). SNM practice guideline for parathyroid scintigraphy 4.0. J Nucl Med Technol, 40(2), 111-118. doi:10.2967/jnmt.112.105122

• 2009

  2009 EANM parathyroid guidelines(2009)

  Greenspan, B. S., Dillehay, G., Intenzo, C., Lavely, W. C., O'Doherty, M., Palestro, C. J., . . . Tulchinsky, M. (2012). SNM practice guideline for parathyroid scintigraphy 4.0. J Nucl Med Technol, 40(2), 111-118. doi:10.2967/jnmt.112.105122

• 2009

  ACR-SNMMI-SPR Practice Guideline for the Performance of Parathyroid Scintigraphy?(2009)

  Gordon, L., Scheff, A., Graham, M., Greenspan, B. S., Lavely, W. C., Gelfand, M. J., . . . Spottswood, S. E. (2009). ACR–SNM–SPR PRACTICE GUIDELINE FOR THE PERFORMANCE OFPARATHYROID SCINTIGRAPHY [Guidelines].

• 2009

  ACR-SNMMI-SPR Practice Guideline for the Performance of Thyroid Scintigraphy and Uptake Measurements?(2009)

  Scheff, A., Spies, W. G., McDougall, R. I., Lavely, W. C., Meier, D., Siegel, B., . . . Spottswood, S. E. (2009). ACR–SNM–SPR PRACTICE GUIDELINE FOR THE PERFORMANCE OF THYROID SCINTIGRAPHY AND UPTAKE MEASUREMENTS [Guidelines]. 6. Retrieved from https://s3.amazonaws.com/rdcms-snmmi/files/production/public/docs/Thyroi...

• 2006

  SNM Procedure Guideline for Scintigraphy for Differentiated Papillary and Follicular Thyroid Cancer(2006)

  Silberstein, E. B., Alavi, A., Balon, H. R., Becker, D., Charkes, D., Clarke, S., . . . Waxman, A. D. (2006). Society of Nuclear Medicine Procedure Guideline for Scintigraphy for Differentiated Papillary and Follicular Thyroid Cancer [Guidelines]. 6. Retrieved from https://s3.amazonaws.com/rdcms-snmmi/files/production/public/docs/Scinti...(9-25-06).pdf

• 2006

  SNM Procedure Guideline for Thyroid Uptake Measurement 3.0?(2006)

  Balon, H. R., Silberstein, E. B., Meier, D., Charkes, D., Royal, H. D., Sarkar, S. D., & Donohoe, K. J. (2006). Society of Nuclear Medicine Procedure Guideline for Thyroid Uptake Measurement 4. Retrieved from https://s3.amazonaws.com/rdcms-snmmi/files/production/public/docs/Thyroi...

• 2006

  SNM Thyroid Scintigraphy 3.0?(2006)

  Balon, H. R., Silberstein, E. B., Meier, D., Charkes, D., Sarkar, S. D., Royal, H. D., & Donohoe, K. J. (2006). Society of Nuclear Medicine Procedure Guideline for Thyroid Scintigraphy [Guidelines]. 10. Retrieved from https://s3.amazonaws.com/rdcms-snmmi/files/production/public/docs/Thyroi...

Imaging

• 2018

  FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0? (2018)

  Boellaard, R., Delgado-Bolton, R., Oyen, W. J., Giammarile, F., Tatsch, K., Eschner, W., . . . Krause, B. J. (2015). FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging, 42(2), 328-354. doi:10.1007/s00259-014-2961-x

• 2013

  EANM-SNMMI Practice Guideline for Tele-Nuclear Medicine 2.0?(2013)

  Parker, J. A., Christian, P., Jadvar, H., Sattler, B., & Wallis, J. W. (2014). The SNMMI and EANM practice guideline for tele-nuclear medicine 2.0. J Nucl Med Technol, 42(1), 15-19. doi:10.2967/jnmt.113.133231

• 2012

  SNM/EANM Guideline for Guideline Development 6.0?(2012)

  Delbeke, D., Chiti, A., Christian, P., Darcourt, J., Donohoe, K., Flotats, A., . . . Royal, H. D. (2012). SNMMI/EANM guideline for guideline development 6.0. J Nucl Med Technol, 40(4), 283-289. doi:10.2967/jnmt.112.108787

• 2010

  SNM General Imaging 6.0?(2010)

  Donohoe, K., Abreu, S., Bartel, T. B., Christian, P., Cullom, S. J., Delbeke, D., . . . Wallis, J. W. (2010). THE SNM PROCEDURE GUIDELINE FOR GENERAL IMAGING 6.0. 26. Retrieved from https://s3.amazonaws.com/rdcms-snmmi/files/production/public/docs/Genera...

• 2009

  EANM procedure guidelines for FDG PET and PET/CT tumour imaging?(2009)

  Boellaard, R., O'Doherty, M. J., Weber, W. A., Mottaghy, F. M., Lonsdale, M. N., Stroobants, S. G., . . . Krause, B. J. (2010). FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol Imaging, 37(1), 181-200. doi:10.1007/s00259-009-1297-4

• 2008

  ACR–SNM–SPR practice guideline for the performance of Scintigraphy for inflammation and infection?(2009)

  Greenspan, B. S., Dillehay, G., Carretta, R.F., Brown, M. L., Gelfand, M.J., Palestro, C. J., . . . Frush, D.P. (2009). ACR–SNM–SPR practice guideline for the performance of Scintigraphy for inflammation and infection.

• 2008

  SNM Recommendations on the use of 18F-FDG PET in oncology?(2008)

  Fletcher, J. W., Djulbegovic, B., Soares, H. P., Siegel, B. A., Lowe, V. J., Lyman, G. H., . . . Shields, A. F. (2008). Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med, 49(3), 480-508. doi:10.2967/jnumed.107.047787

• 2006

  SNM Procedure Guideline for SPECT/CT Imaging?(2006)

  Delbeke, D., Coleman, R. E., Guiberteau, M. J., Brown, M. L., Royal, H. D., Siegel, B. A., . . . Cronin, V. (2006). Procedure Guideline for SPECT/CT Imaging 1.0. J Nucl Med, 47(7), 1227-1234.

• 2006

  SNM Procedure Guideline for Tumor Imaging with 18F-FDG PET/CT 1.0?(2006)

  Delbeke, D., Coleman, R. E., Guiberteau, M. J., Brown, M. L., Royal, H. D., Siegel, B. A., . . . Holbrook, S. (2006). Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0. J Nucl Med, 47(5), 885-895.

Oncology: Bone Tumours

• 2019

  18F-NaF-PET/CT for the detection of bone metastasis in prostate cancer: a meta-analysis of diagnostic accuracy studies.

  Sheikhbahaei, S., Jones, K. M., Werner, R. A., Salas-Fragomeni, R. A., Marcus, C. V., Higuchi, T., . . . Javadi, M. S. (2019). (18)F-NaF-PET/CT for the detection of bone metastasis in prostate cancer: a meta-analysis of diagnostic accuracy studies. Ann Nucl Med, 33(5), 351-361. doi:10.1007/s12149-019-01343-y

• 2019

  Bone marrow examination in patients with Ewing sarcoma/peripheral primitive neuroectodermal tumor without metastasis based on?18F-fluorodeoxyglucose positron emission tomography/computed tomography.

  Inagaki, C., Shimoi, T., Sumiyoshi Okuma, H., Kawachi, A., Sudo, K., Shimomura, A., . . . Tamura, K. (2019). Bone marrow examination in patients with Ewing sarcoma/peripheral primitive neuroectodermal tumor without metastasis based on (18)F-fluorodeoxyglucose positron emission tomography/computed tomography. Med Oncol, 36(7), 58. doi:10.1007/s12032-019-1279-8

• 2019

  Hybrid Imaging (PET-Computed Tomography/PET-MR Imaging) of Bone Metastases.

  Schmidkonz, C., Ellmann, S., Ritt, P., Roemer, F. W., Guermazi, A., Uder, M., . . . B?uerle, T. (2019). Hybrid Imaging (PET-Computed Tomography/PET-MR Imaging) of Bone Metastases. PET Clin, 14(1), 121-133. doi:10.1016/j.cpet.2018.08.003

• 2019

  Skeletal Metastasis Evaluation: Value and Impact of PET/Computed Tomography on Diagnosis, Management and Prognosis.

  Broski, S. M., Young, J. R., Kendi, A. T., & Subramaniam, R. M. (2019). Skeletal Metastasis Evaluation: Value and Impact of PET/Computed Tomography on Diagnosis, Management and Prognosis. PET Clin, 14(1), 103-120. doi:10.1016/j.cpet.2018.08.006

• 2019

  The diagnostic performance of?18F-fluoride PET/CT in bone metastases detection: a meta-analysis.

  Liu, Y., Sheng, J., Dong, Z., Xu, Y., Huang, Q., Pan, D., . . . Yang, M. (2019). The diagnostic performance of (18)F-fluoride PET/CT in bone metastases detection: a meta-analysis. Clin Radiol, 74(3), 196-206. doi:10.1016/j.crad.2018.12.011

• 2018

  Applications of PET/CT and PET/MR Imaging in Primary Bone Malignancies.

  Behzadi, A. H., Raza, S. I., Carrino, J. A., Kosmas, C., Gholamrezanezhad, A., Basques, K., . . . Jadvar, H. (2018). Applications of PET/CT and PET/MR Imaging in Primary Bone Malignancies. PET Clin, 13(4), 623-634. doi:10.1016/j.cpet.2018.05.012

• 2018

  Diagnostic performance of choline PET/CT for the detection of bone metastasis in prostate cancer: A systematic review and meta-analysis.

  Guo, Y., Wang, L., Hu, J., Feng, D., & Xu, L. (2018). Diagnostic performance of choline PET/CT for the detection of bone metastasis in prostate cancer: A systematic review and meta-analysis. PLOS ONE, 13(9), e0203400. doi:10.1371/journal.pone.0203400

• 2016

  Assessing the role of 1?F-FDG PET and 1?F-FDG PET/CT in the diagnosis of soft tissue musculoskeletal malignancies: a systematic review and meta-analysis.

  Etchebehere, E. C., Hobbs, B. P., Milton, D. R., Malawi, O., Patel, S., Benjamin, R. S., & Macapinlac, H. A. (2016). Assessing the role of 1?F-FDG PET and 1?F-FDG PET/CT in the diagnosis of soft tissue musculoskeletal malignancies: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging, 43(5), 860-870. doi:10.1007/s00259-015-3242-z

• 2016

  Positron emission tomography (18)F-fluorodeoxyglucose uptake and prognosis in patients with bone and soft tissue sarcoma: A meta-analysis.

  Li, Y. J., Dai, Y. L., Cheng, Y. S., Zhang, W. B., & Tu, C. Q. (2016). Positron emission tomography (18)F-fluorodeoxyglucose uptake and prognosis in patients with bone and soft tissue sarcoma: A meta-analysis. Eur J Surg Oncol, 42(8), 1103-1114. doi:10.1016/j.ejso.2016.04.056

Oncology: Endocrine Tumours

• 2019

  Current status of functional imaging in neuroblastoma, pheochromocytoma, and paraganglioma disease.

  Kroiss, A. S. (2019). Current status of functional imaging in neuroblastoma, pheochromocytoma, and paraganglioma disease. Wien Med Wochenschr, 169(1-2), 25-32. doi:10.1007/s10354-018-0658-7

• 2018

  Neuroendocrine Tumor Diagnosis and Management:?68Ga-DOTATATE PET/CT.

  Sanli, Y., Garg, I., Kandathil, A., Kendi, T., Zanetti, M. J. B., Kuyumcu, S., & Subramaniam, R. M. (2018). Neuroendocrine Tumor Diagnosis and Management: (68)Ga-DOTATATE PET/CT. AJR Am J Roentgenol, 211(2), 267-277. doi:10.2214/ajr.18.19881

• 2018

  The utility of?68Ga-DOTATATE positron-emission tomography/computed tomography in the diagnosis, management, follow-up and prognosis of?neuroendocrine tumors.

  Tirosh, A., & Kebebew, E. (2018). The utility of (68)Ga-DOTATATE positron-emission tomography/computed tomography in the diagnosis, management, follow-up and prognosis of neuroendocrine tumors. Future Oncol, 14(2), 111-122. doi:10.2217/fon-2017-0393

• 2017

  Guideline for PET/CT imaging of neuroendocrine neoplasms with?68Ga-DOTA-conjugated somatostatin receptor targeting peptides and?18F-DOPA.

  Bozkurt, M. F., Virgolini, I., Balogova, S., Beheshti, M., Rubello, D., Decristoforo, C., . . . Fanti, S. (2017). Guideline for PET/CT imaging of neuroendocrine neoplasms with (68)Ga-DOTA-conjugated somatostatin receptor targeting peptides and (18)F-DOPA. Eur J Nucl Med Mol Imaging, 44(9), 1588-1601. doi:10.1007/s00259-017-3728-y

• 2017

  Utility of I-124 PET/CT in identifying radioiodine avid lesions in differentiated thyroid cancer: a systematic?review?and meta-analysis.

  Santhanam, P., Taieb, D., Solnes, L., Marashdeh, W., & Ladenson, P. W. (2017). Utility of I-124 PET/CT in identifying radioiodine avid lesions in differentiated thyroid cancer: a systematic review and meta-analysis. Clin Endocrinol (Oxf), 86(5), 645-651. doi:10.1111/cen.13306

• 2016

  68Ga-DOTATATE Compared with 111In-DTPA-Octreotide and Conventional Imaging for Pulmonary and Gastroenteropancreatic?Neuroendocrine Tumors: A Systematic Review and Meta-Analysis.

  eppen, S. A., Blume, J., Bobbey, A. J., Shah, C., Graham, M. M., Lee, P., . . . Walker, R. C. (2016). 68Ga-DOTATATE Compared with 111In-DTPA-Octreotide and Conventional Imaging for Pulmonary and Gastroenteropancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis. J Nucl Med, 57(6), 872-878. doi:10.2967/jnumed.115.165803

Physics

• 2010

  EANM Acceptance Testing for Nuclear Medicine Instrumentation?(2010)

  Busemann Sokole, E., P?achcínska, A., & Britten, A. (2010). Acceptance testing for nuclear medicine instrumentation. Eur J Nucl Med Mol Imaging, 37(3), 672-681. doi:10.1007/s00259-009-1348-x

• 2010

  EANM Routine Quality Control Recommendations for Nuclear Medicine Instrumentation?(2010)

  Busemann Sokole, E., P?achcínska, A., Britten, A., Lyra Georgosopoulou, M., Tindale, W., & Klett, R. (2010). Routine quality control recommendations for nuclear medicine instrumentation. Eur J Nucl Med Mol Imaging, 37(3), 662-671. doi:10.1007/s00259-009-1347-y

Radiopharmacy

• 2016

  Position paper on requirements for toxicological studies in the specific case of radiopharmaceuticals?(2016)

  Busemann Sokole, E., P?achcínska, A., Britten, A., Lyra Georgosopoulou, M., Tindale, W., & Klett, R. (2010). Routine quality control recommendations for nuclear medicine instrumentation. Eur J Nucl Med Mol Imaging, 37(3), 662-671. doi:10.1007/s00259-009-1347-y

• 2014

  Guidance on current good radiopharmacy practice for the small-scale preparation of radiopharmaceuticals using automated modules: a European perspective?(2014)

  Aerts, J., Ballinger, J. R., Behe, M., Decristoforo, C., Elsinga, P. H., Faivre-Chauvet, A., . . . Koziorowski, J. (2014). Guidance on current good radiopharmacy practice for the small-scale preparation of radiopharmaceuticals using automated modules: a European perspective. J Labelled Comp Radiopharm, 57(10), 615-620. doi:10.1002/jlcr.3227

• 2011

  ACR-SNMMI Technical Standard for Diagnostic Procedures Using Radiopharmaceuticals?(2011).

  Henkin, R. E., Fig, L. M., Greenspan, B. S., Palestro, C. J., Walker, R. C., Dragotakes, S. D., . . . Ponto, J. A. (2011a). ACR–SNM TECHNICAL STANDARD FOR DIAGNOSTIC PROCEDURES USING RADIOPHARMACEUTICALS [Guidelines]. 8. Retrieved from https://s3.amazonaws.com/rdcms-snmmi/files/production/public/docs/ACR-SN...

• 2010

  Guidelines on current good Radiopharmacy Practice (cGRPP) for the small-scale preparations of radiopharmaceuticals?(2010)

  Elsinga, P., Todde, S., Penuelas, I., Meyer, G., Farstad, B., Faivre-Chauvet, A., . . . Decristoforo, C. (2010). Guidance on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals. Eur J Nucl Med Mol Imaging, 37(5), 1049-1062. doi:10.1007/s00259-010-1407-3

• 2007

  Guidelines on current good Radiopharmacy Practice (cGRPP) in the Preparation of Radiopharmaceuticals (2007)

  European Association of Nuclear Medicine. (2007). [Guidelines]. 19. Retrieved from https://www.eanm.org/publications/guidelines/gl_radioph_cgrpp.pdf

• 2004

  Use of Radiopharmaceuticals 4.0?(2004)

  Callahan, R. J., Chilton, H. M., Ponto, J. A., Swanson, D. P., Royal, H. D., & Bruce, A. D. (2007). Procedure guideline for the use of radiopharmaceuticals 4.0. J Nucl Med Technol, 35(4), 272-275. doi:10.2967/jnmt.107.044156

Technologists guidelines

• 2010

  Principles and Practice of PET/CT Part 1?(2010)

  Dennan, S., Kane, T., Vrigneaud, J. M., Prevot, S., Meadows, A., Boellaard, R., . . . Cola, S. (2010). Principles and Practice of PET/CT Part 1 In P. Hogg & G. Testanera (Eds.), (pp. 101). Retrieved from https://www.eanm.org/publications/guidelines/gl_Principles_and_Practice_...

• 2001

  Advanced Performance and Responsibility Guidelines?(2001)

  Eustance, C., van den Broek, W., Prevot, S., Fischer, S., Steien, Z., Petrovic, Z., . . . Jorge, J. P. (2001). Advanced Performance and Responsibility Guidelines for the Nuclear Medicine Technologist [Guidelines]. 11. Retrieved from https://www.eanm.org/content-eanm/uploads/2017/02/Advanced-Performance-a...

• 2001

  Patient information leaflets?(2001)

  Dickinson, D., Raynor, D. K., & Duman, M. (2001). Patient information leaflets for medicines: using consumer testing to determine the most effective design. Patient Educ Couns, 43(2), 147-159. doi:10.1016/s0738-3991(00)00156-7